{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:06:27Z","timestamp":1758477987875},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","sfnmjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.siny.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T05:15:39Z","timestamp":1520486139000},"page":"267-272","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Continued uncertainty regarding treatment of patent ductus arteriosus in premature infants and the role of clinical trials"],"prefix":"10.1016","volume":"23","author":[{"given":"Edmund","family":"Juszczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2018.03.004_bib1","unstructured":"The James Lind Library [http:\/\/www.jameslindlibrary.org\/] and Wikipedia."},{"key":"10.1016\/j.siny.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0022-3476(83)80022-5","article-title":"Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study","volume":"102","author":"Gersony","year":"1983","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1542\/peds.93.4.543","article-title":"Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial","volume":"93","author":"Ment","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2018.03.004_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials","volume":"276","author":"Begg","year":"1996","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.siny.2018.03.004_bib5","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJM200106283442602","article-title":"Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants","volume":"344","author":"Schmidt","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2018.03.004_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-121-3-199408010-00008","article-title":"The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results","volume":"121","author":"Goodman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.siny.2018.03.004_bib7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3730","article-title":"Patent ductus arteriosus in preterm infants","volume":"137","author":"Benitz","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2018.03.004_bib8","doi-asserted-by":"crossref","first-page":"F505","DOI":"10.1136\/archdischild-2013-303816","article-title":"Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3","volume":"98","author":"Sellmer","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2018.03.004_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0035-1571202","article-title":"Short- and long-term outcomes for extremely preterm infants","volume":"33","author":"Patel","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.siny.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmj.314.7074.107","article-title":"Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994","volume":"314","author":"Tin","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.siny.2018.03.004_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7976","article-title":"Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies)","volume":"345","author":"Costeloe","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.siny.2018.03.004_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.siny.2015.03.004","article-title":"Preterm patent ductus arteriosus: a continuing conundrum for the neonatologist?","volume":"20","author":"Evans","year":"2015","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.siny.2018.03.004_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005362","article-title":"Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study","volume":"4","author":"Ye","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.siny.2018.03.004_bib14","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1100441","article-title":"Treatment of neonatal sepsis with intravenous immune globulin","volume":"365","author":"Brocklehurst","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.siny.2018.03.004_bib15","article-title":"Intravenous immunoglobulin for suspected or proven infection in neonates","author":"Ohlsson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2018.03.004_bib16","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: greater precision but with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.siny.2018.03.004_bib17","doi-asserted-by":"crossref","first-page":"F193","DOI":"10.1136\/archdischild-2014-306730","article-title":"Accounting for deaths in neonatal trials: is there a correct approach?","volume":"100","author":"Parekh","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2018.03.004_bib18","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.jacc.2015.10.023","article-title":"Statistical controversies in reporting of clinical trials: part 2 of a 4-part series on statistics for clinical trials","volume":"66","author":"Pocock","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.siny.2018.03.004_bib19","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.jacc.2015.10.051","article-title":"Challenging issues in clinical trial design: part 4 of a 4-part series on statistics for clinical trials","volume":"66","author":"Pocock","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.siny.2018.03.004_bib20","unstructured":"EMEA\/CPMP\/EWP\/908\/99. Points to consider on multiplicity issues in clinical trials. (September 2002)."},{"key":"10.1016\/j.siny.2018.03.004_bib21","unstructured":"MRC Clinical Trials Unit. MAMS design [http:\/\/www.ctu.mrc.ac.uk\/our_research\/research_types\/methodology1\/design\/mams_design\/]."}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X1830043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X1830043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T16:18:44Z","timestamp":1660580324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X1830043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1744165X1830043X"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2018.03.004","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continued uncertainty regarding treatment of patent ductus arteriosus in premature infants and the role of clinical trials","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}